NICOLINI GABRIELLA

Cadamuro, F., Piazzoni, M., Borghi, I., Baeri, A., Fumagalli, A., Perillo, F., et al. (2026). 3D Bioprinted Glioblastoma Multiforme Models: How the Extracellular Matrix Glycosignature Influences Drug Response. ADVANCED FUNCTIONAL MATERIALS [10.1002/adfm.77772]. Dettaglio

Melgari, D., Calamaio, S., Frosio, A., Prevostini, R., Malacrida, A., Anastasia, L., et al. (2026). Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and Carfilzomib. FRONTIERS IN DRUG DISCOVERY, 6, 1-14 [10.3389/fddsv.2026.1774061]. Dettaglio

Nicolini, G., Cadamuro, F., Baeri, A., Ghizzi, M., Rivara, M., Bravin, A., et al. (2026). Imaging and molecular characterizaton of a new 3D bioprinted glioblastoma model for drug screening. Intervento presentato a: 79° Congresso Nazionale della Società Italiana di Anatomia e Istologia (SIAI) - 10/11/12 Settembre 2026, L’Aquila, Italia. Dettaglio

Cavaletti, G., Canta, A., Chiorazzi, A., Ballarini, E., Rodriguez, V., Scuteri, A., et al. (2026). Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model. PAIN REPORTS, 11(2) [10.1097/PR9.0000000000001395]. Dettaglio

Rivara, M., Malacrida, A., Ghizzi, M., Bentivegna, A., Sica, F., Re, F., et al. (2026). Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment. BIOLOGY, 15(16) [10.3390/biology15161371]. Dettaglio